IBDEI0MQ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10119,1,3,0)
 ;;=3^Branch Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,10119,1,4,0)
 ;;=4^H34.231
 ;;^UTILITY(U,$J,358.3,10119,2)
 ;;=^5005564
 ;;^UTILITY(U,$J,358.3,10120,0)
 ;;=H34.232^^74^670^2
 ;;^UTILITY(U,$J,358.3,10120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10120,1,3,0)
 ;;=3^Branch Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,10120,1,4,0)
 ;;=4^H34.232
 ;;^UTILITY(U,$J,358.3,10120,2)
 ;;=^5005565
 ;;^UTILITY(U,$J,358.3,10121,0)
 ;;=H35.031^^74^670^17
 ;;^UTILITY(U,$J,358.3,10121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10121,1,3,0)
 ;;=3^Hypertensive Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,10121,1,4,0)
 ;;=4^H35.031
 ;;^UTILITY(U,$J,358.3,10121,2)
 ;;=^5005590
 ;;^UTILITY(U,$J,358.3,10122,0)
 ;;=H35.032^^74^670^18
 ;;^UTILITY(U,$J,358.3,10122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10122,1,3,0)
 ;;=3^Hypertensive Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,10122,1,4,0)
 ;;=4^H35.032
 ;;^UTILITY(U,$J,358.3,10122,2)
 ;;=^5005591
 ;;^UTILITY(U,$J,358.3,10123,0)
 ;;=H35.033^^74^670^19
 ;;^UTILITY(U,$J,358.3,10123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10123,1,3,0)
 ;;=3^Hypertensive Retinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,10123,1,4,0)
 ;;=4^H35.033
 ;;^UTILITY(U,$J,358.3,10123,2)
 ;;=^5005592
 ;;^UTILITY(U,$J,358.3,10124,0)
 ;;=H35.82^^74^670^23
 ;;^UTILITY(U,$J,358.3,10124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10124,1,3,0)
 ;;=3^Retinal Ischemia/Cotton Wool Spot
 ;;^UTILITY(U,$J,358.3,10124,1,4,0)
 ;;=4^H35.82
 ;;^UTILITY(U,$J,358.3,10124,2)
 ;;=^5005716
 ;;^UTILITY(U,$J,358.3,10125,0)
 ;;=H35.61^^74^670^21
 ;;^UTILITY(U,$J,358.3,10125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10125,1,3,0)
 ;;=3^Retinal Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,10125,1,4,0)
 ;;=4^H35.61
 ;;^UTILITY(U,$J,358.3,10125,2)
 ;;=^5005699
 ;;^UTILITY(U,$J,358.3,10126,0)
 ;;=H35.62^^74^670^22
 ;;^UTILITY(U,$J,358.3,10126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10126,1,3,0)
 ;;=3^Retinal Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,10126,1,4,0)
 ;;=4^H35.62
 ;;^UTILITY(U,$J,358.3,10126,2)
 ;;=^5005700
 ;;^UTILITY(U,$J,358.3,10127,0)
 ;;=H35.051^^74^670^24
 ;;^UTILITY(U,$J,358.3,10127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10127,1,3,0)
 ;;=3^Retinal Neovascularization,Right Eye
 ;;^UTILITY(U,$J,358.3,10127,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,10127,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,10128,0)
 ;;=H35.052^^74^670^25
 ;;^UTILITY(U,$J,358.3,10128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10128,1,3,0)
 ;;=3^Retinal Neovascularization,Left Eye
 ;;^UTILITY(U,$J,358.3,10128,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,10128,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,10129,0)
 ;;=H35.071^^74^670^26
 ;;^UTILITY(U,$J,358.3,10129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10129,1,3,0)
 ;;=3^Retinal Telangiectasis,Right Eye
 ;;^UTILITY(U,$J,358.3,10129,1,4,0)
 ;;=4^H35.071
 ;;^UTILITY(U,$J,358.3,10129,2)
 ;;=^5005606
 ;;^UTILITY(U,$J,358.3,10130,0)
 ;;=H35.072^^74^670^27
 ;;^UTILITY(U,$J,358.3,10130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10130,1,3,0)
 ;;=3^Retinal Telangiectasis,Left Eye
 ;;^UTILITY(U,$J,358.3,10130,1,4,0)
 ;;=4^H35.072
 ;;^UTILITY(U,$J,358.3,10130,2)
 ;;=^5005607
 ;;^UTILITY(U,$J,358.3,10131,0)
 ;;=H35.061^^74^670^28
 ;;^UTILITY(U,$J,358.3,10131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10131,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
